The hidden cost of chemical alternatives: when replacements prove as toxic as the originals
In short: When regulators phased out dangerous long-chain PFAS, industry introduced new alternatives. However, investigations near a New Jersey manufacturing facility reveal these new chemicals might be just as bioaccumulative and toxic, often remaining unknown to the public and authorities until environmental contamination is already widespread.
The transition from legacy long-chain perfluoroalkyl acids (PFAAs) to shorter-chain alternatives was intended to mitigate health risks. However, research has identified a concerning trend where alternative PFAS, such as chloroperfluoropolyether carboxylates (ClPFECAs), may be at least as toxic and bioaccumulative in rats as the substances they replaced. In some cases, these alternatives have been released into the air and water for many years without the knowledge of regulators or the public. This issue was highlighted by a joint study involving the United States Environmental Protection Agency and the New Jersey Department of Environmental Protection. Such findings emerged after a legal directive forced the disclosure of information regarding these specific substances.
The human impact of these substances is significant. Data from exposed workers indicates that ClPFECAs possess a human half-life spanning several years and are linked to various health endpoints. Because of these risks, the protective water concentration levels required to prevent chronic exposure to these alternatives are actually lower than the benchmarks previously established for the original long-chain PFAAs.
This situation highlights a critical regulatory gap. When alternative chemicals are used without being disclosed to authorities, they can create substantial human health risks that bypass existing safety frameworks. Addressing these 'unknown' risks requires proactive identification to allow for timely regulatory intervention and to prevent future environmental contamination.
The complexity of managing these substances is compounded by the fact that they are often used in specialized manufacturing, such as fluoropolymer production, making their presence in the environment difficult to track until significant exposure has occurred.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Obtaining and Evaluating Information on the Use, Release, and Health Effects of Two Types of Long-Chain PFAS Used as Alternatives for Legacy Long-Chain Perfluoroalkyl Acids: A Case Study.
- Also: Solvay S.A.
To cite this card, link to https://intellectplus.co.uk/app/health-solvay-s-a.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Future Frontier · More in Health · Latest · A–Z · All topics